Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
Seminars in Oncology|December 1, 1990
Overview of hormonal therapy in advanced breast cancerL P Schacter, M Rozencweig, R Canetta, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
N-(Phosphonacetyl)-L-aspartate (PALA): current statusM Rozencweig, R Abele, M Piccart, et al.
Journal of Steroid Biochemistry|December 1, 1985
Aminoglutethimide and estrogenic stimulation before chemotherapy for treatment of advanced breast cancer. Preliminary results of a phase II study conducted by the E.O.R.T.C. Breast Cancer Cooperative GroupR Paridaens, J B Van der Wijst, J P Julien, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1986
Phase II study of a combination of hydroxyurea, fluorouracil and mitomycin in previously treated squamous cell carcinoma of the head and neckP Dodion, F Cognetti, M van Rymenant, et al.
Investigational New Drugs|August 1, 1990
Phase II study of tallysomycin S10b in patients with advanced head and neck cancerC Nicaise, W K Hong, W Dimery, et al.
The American Journal of Medicine|February 1, 1977
Daunomycin-induced cardiotoxicity in children and adults. A review of 110 casesD D Von Hoff, M Rozencweig, M Layard, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1988
Comparative effect of cisplatin, spiroplatin, carboplatin, iproplatin and JM40 in a human myeloid clonogenic assayW A Schroyens, J B Meeker, P Dodion, et al.
Investigational New Drugs|January 1, 1984
Phase II study of carminomycin in a human tumor cloning assayM Rozencweig, C Sanders, W Rombaut, et al.
Cancer Chemotherapy and Pharmacology|December 1, 1982
Combination of dacarbazine and mitomycin in advanced colorectal cancerH Bleiberg, M Clavel, C Nicaise, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Assessment of estrogenic recruitment before chemotherapy in advanced breast cancer: a double-blind randomized study. European Organization for Research and Treatment of Cancer Breast Cancer Cooperative GroupR Paridaens, J C Heuson, J P Julien, et al.
Pageof 13